当前位置: 首页 > 期刊 > 《中国中药杂志》 > 2012年第23期
编号:13175090
国内中、西医治疗脑卒中的药物经济学研究概况(4)
http://www.100md.com 2012年12月1日 《中国中药杂志》 2012年第23期
     [22] 高志嵩,张淑敏. 卒中单元对急性脑卒中治疗的效果评价[J]. 宁夏医学杂志, 2007, 29(1):36.

    [23] 何庆勇,王阶,王师茜,等. 急性脑梗死的卫生经济学研究[J]. 世界科学技术——中医药现代化, 2007, 9(4):31.

    [24] 高凡珠. 基于数据包络分析的缺血性中风早期康复中医综合方案疗效评价[D]. 北京:中国中医科学院,2010.

    [25] 王曼,杜珺,张方. 急性缺血性脑卒中的成本-效果分析——基于中国人群的Markov矩阵分析[J]. 中国药房, 2010, 21(34):3174.

    [26] 郑敏,李晓松,朱彩蓉. 预防脑卒中复发长期效果的决策分析模型[J]. 现代预防医学, 2008, 35(12):2209.

    Overview of pharmacoeconomic studies on traditional Chinese medicines and western medicines in treatment of stroke

    CHANG Yan-peng, XIE Yan-ming

    (1. Post-doctoral Station, China Academy of Chinese Medical Sciences, Beijing 100700, China;

    2. Institute of Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China)

    [Abstract] In recent years, pharmacoeconomic studies have drawn increasing attention from experts in clinical medicine, pharmacy, health economics and health management. Their findings play an important role in drug pricing, drafting of the List of Essential Medicines and rational selection of clinical drugs. The essay summarizes the literatures published in recent years concerning pharmacoeconomics of traditional Chinese medicines on stroke, in order to make clear the current development of the latest studies on traditional Chinese medicines on treating stroke and rehabilitation methods and provide basis for further studies on pharmacoeconomics of traditional Chinese medicines on stroke and reference for rational clinical drug use.

    [Key words] stroke; pharmacoeconomics; summary

    doi:10.4268/cjcmm20122301

    [责任编辑 陈玲], http://www.100md.com(常艳鹏 谢雁鸣)
上一页1 2 3 4